Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Aerskaaerska.com · Low evidenceAerska develops RNA medicines designed to treat, delay, and prevent brain diseases by silencing harmful genes. The company focuses on targeted delivery of RNAi therapies to the brain through systemic administration and brain shuttle technologies.
Parse Score